Real-world check for GORE TAMBE device in tough aortic aneurysms

NCT ID NCT06578741

Ongoing Disease control Sponsor: W.L.Gore & Associates Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study follows 300 people who received the GORE TAMBE device to treat complex aortic aneurysms. The goal is to confirm the device works safely and effectively outside of clinical trials. Researchers will track technical success and patient outcomes over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) – a stent graft device
What this could lead to: If successful, this study confirms the device is safe and effective for treating complex aortic aneurysms in everyday practice.
What could go wrong: This is a post-approval study, not a new treatment test. It mainly monitors real-world outcomes, so no major breakthroughs are expected. Risks include device complications like leaks or blockages.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm aortic aneurysm Aortic Aneurysm, Thoracoabdominal thoracic aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABDOMINAL AORTIC ANEURYSM PARARENAL AORTIC ANEURYSM THORACOABDOMINAL AORTIC ANEURYSM

Real-world check for GORE TAMBE device in tough aortic aneurysms

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions